132 filings
Page 3 of 7
8-K
t60p0db3csg
2 Nov 20
IVERIC bio Reports Third Quarter 2020 Operational Highlights and Financial Results
7:07am
8-K
xfg5k x2ei6ax0so
5 Aug 20
IVERIC bio Reports Second Quarter 2020 Operational Highlights and Financial Results
7:07am
8-K
whthgisngxn
17 Jul 20
Departure of Directors or Certain Officers
4:04pm
8-K
kmyhgry47
19 Jun 20
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
4:23pm
8-K
gpnxuxsdbq3ijp1uax
17 Jun 20
Other Events
4:13pm
8-K
00hp1c2m3
15 Jun 20
Other Events
6:19am
8-K
tfu8wvmzlbkcn0
10 Jun 20
Submission of Matters to a Vote of Security Holders
9:08am
8-K
dbx356
6 May 20
IVERIC bio Reports First Quarter 2020 Operational Highlights and Financial Results
7:12am
8-K
ze195134k20kmhv
18 Mar 20
Other Events
8:04am
8-K
g9y4r0 uxmf4
27 Feb 20
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results
7:09am
8-K
cmrez wdx
13 Jan 20
IVERIC bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
8:03am
8-K
kk8co55oguy2 u4
10 Dec 19
IVERIC bio, Inc. Announces Pricing of Public Offering of Common Stock
7:06am
8-K
fkwqfhidezbs5v ty
12 Nov 19
IVERIC bio Reports Third Quarter 2019 Operational Highlights and Financial Results
7:10am
8-K
5qiqm5yoxy
28 Oct 19
Other Events
6:38am
8-K
2vfmt2t8 go6m
9 Oct 19
Departure of Directors or Certain Officers
7:59am
8-K
5jqst
14 Aug 19
Regulation FD Disclosure
12:00am
8-K
ze70pkxgv0gmuwijetfe
1 Aug 19
IVERIC bio Reports Second Quarter 2019 Financial and Operating Results
7:26am
8-K
fmrn6frkbvnt5aov1lul
23 Jul 19
Entry into a Material Definitive Agreement
8:14am
8-K
oa8rsw q54p
16 May 19
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
bgklseqlbub7
8 May 19
IVERIC bio Reports First Quarter 2019 Financial and Operating Results
7:39am